Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Finding the right no fee credit card that offers travel insurance can save you money and provide peace of mind. Explore your options today!
23,904 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Vistra surged dramatically, but does the rally leave room for gains or is the stock now a trap for late buyers? This ...
An AI forecast from Claude points to multix gains for XRP, Solana, and Dogecoin by 2026. The predictions hinge on ado...
As 2026 unfolds, the tax on Social Security depends on three numbers, not the payout amount. This guide breaks down h...
Keurig Dr Pepper reported stronger-than-expected Q4 results and unveiled an $18 billion deal to acquire JDE Peet's, p...
The administration re-ignites a plan to bar large investors from single-family home purchases. Analysts question whet...
Four dividend stocks flying under the radar are stepping into the spotlight as they lift dividends and beat Q4 estima...
A look at WWII-era weapons that helped allies reveals how innovation and mass production built a durable defense base...
Analysts are shifting their stance on Palantir, suggesting upside potential after a period of mixed momentum. This gu...
When a billionaire like David Tepper reportedly sold stakes in Nvidia and Amazon, it raises questions for regular inv...
Goldman Sachs flags four tech, media, and telecom bets on its Conviction List, each carrying 40% to 100% upside to ta...
As traders watch OpenAI roll out GPT-5.4 just days after a wave of defections, the move highlights how AI advances in...